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The aim of the present study was to evaluate in HIV-positive patients with bacterial pneumonia, the 
diagnostic value of a new endoscopic technique that uses a single catheter to perform a telescopic 
plugged catheter (TPC) followed by a modified protected bronchoalveolar lavage (mpBAL). Fifty-eight 
HIV-positive patients with respiratory infection were included in the study. Samples from TPC and 
mpBAL were cultured quantitatively. Standard bronchoalveolar lavage was performed to rule out 
opportunistic infections. According to the clinical and microbiological results, patients were classified in 
the study group (27 with bacterial pneumonia) or the control group (31 without bacterial pneumonia). 
Sensitivity of TPC was 56% [95% confidence intervals (CI) 37-7.5%] and its specificity was 100%; these 
figures were 56% (CI, 37-75%) and 94% (CI, 86-100%) for mpBAL. When both techniques were assessed 
together, sensitivity increased to 70% (CI, 53-87%). The use of a single catheter reduced the cost of the 
originally described pBAL procedure by approximately 50%. The use of a single catheter to perform a 
TPC followed by a mpBAL can improve the diagnostic yield in HIV-positive patients with bacterial 
pneumonia, and reduces its cost. 
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Introduction 
Pneumonia often complicates the clinical course of 
patients infected with the human immunodeficiency 
virus (HIV) (l-3). In these patients, the broncho- 
alveolar lavage (BAL) and the telescoping plugged 
catheter (TPC) are useful techniques in the diagnosis 
of diffuse pulmonary infiltrates (4-9). Recently, 
Meduri et al. (10) reported that protected broncho- 
alveolar lavage (pBAL) enhances the retrieval of 
uncontaminated distal airway secretions in immuno- 
competent patients with bacterial pneumonia (10). 
The role of pBAL in HIV-positive patients has not 
yet been assessed. On the other hand, to reduce the 
cost of the original catheter described by Meduri et al. 
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(lo), Castella et al. (11) used a standard TPC catheter 
to perform a pBAL in immunocompetent patients 
with bacterial pneumonia. The clinical usefulness of 
this latter approach has not been assessed either in 
HIV-positive patients with respiratory infection. The 
present investigation sought to evaluate the diag- 
nostic value of a new technique that consists of a TPC 
and modified pBAL (mpBAL) performed sequen- 
tially through a single catheter in HIV-positive 
patients hospitalized because of bacterial pneumonia. 
Methods 
PATIENTS 
Fifty-eight consecutive patients (46 male and 12 
female), 33 i 8 years (mean -+ SD), were prospectively 
recruited. All of them were HIV-positive [enzyme- 
linked immunosorbent assay (ELISA) and Western 
Blot]. Forty patients were intravenous drug abusers; 
the rest were homosexual. All of them were hospital- 
ized because of an acute respiratory infection, defined 
by the presence of at least three of the following 
criteria: (1) new solitary or diffuse pulmonary 
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infiltrates in the chest roentgenogram; (2) axillary 
temperature >37.5”C; (3) purulent sputum; (4) 
arterial PaO, < IO.6 kPa (breathing room air); (5) 
persistent cough; and (6) abnormal respiratory 
sounds. Patients were excluded from the study if they 
had an arterial PaO, ~8 kPa despite the admin- 
istration of supplemental 0, and/or they had received 
antibiotics prior to the bronchoscopic examination. 
According to the clinical and microbiological results 
(see below), patients were allocated into one of the 
two groups: the study group (HIV-positive patients 
with bacterial pneumonia) or the control group 
(HIV-positive patients without bacterial pneumonia). 
PROTOCOL 
The protocol was approved by the local Ethics 
Committee. After wedging the tip of the broncho- 
scope in the pulmonary segment with the highest 
radiological involvement (in those cases with focal 
infiltrates), or in the lingula or middle right lobe (in 
those cases with diffuse infiltrates), a single catheter 
was used to perform a TPC followed by a mpBAL 
(see below). Finally, a standard BAL was done 
to identify opportunistic infections, particularly, 
Pneurnocystis carinii. 
ENDOSCOPIC METHODS 
Subcutaneous atropine (0.5 mg) was administered 
before the procedure and topical anaesthesia with 2% 
lignocaine was used throughout. The bronchoscope 
(Olympus BF-T2 or BF-10, Olympus Corporation, 
New York, U.S.A.) was introduced transnasally with- 
out aspirating the upper airway secretions and mini- 
mizing the amount of anaesthesia instilled. The TPC 
procedure was carried out following the standard 
method (12). Briefly, a telescoping plugged catheter 
(Mill-Rose Lab, U.S.A.) was inserted through the 
inner suction channel, until it could be seen at the tip 
of the bronchoscope. The inner catheter was 
advanced 34 cm to displace the plug; by advancing 
the brush, the specimen was obtained. The brush was 
withdrawn into the catheter, and the entire catheter 
was removed from the bronchoscope. Next, the brush 
was aseptically cut in a tube containing 1 ml of sterile 
saline. To perform the mpBAL, the same catheter 
(and metal guide) used for TPC were re-introduced 
in the same pulmonary segment. Under sterile con- 
ditions, the proximal extreme of the TPC brush 
was cut (1 l), the metal guide was withdrawn and a 
syringe was connected, using a screw connector 
(Schraubkupplung ch6-12, b. Braun, Melsungen, 
Germany). Thirty millilitres of sterile saline solution 
were instilled. Approximately 30% of the initial 
Auid volume was recovered. In any patient, less than 
5 ml was recovered. The standard BAL was carried 
out with 150 ml of sterile saline solution (divided into 
six aliquots of 25 ml) following standard recommen- 
dations. The same pulmonary segment sampled with 
the TPC and mpBAL was used for BAL. 
MICROBIOLOGICAL TECHNIQUES 
Telescopic plugged catheter and mpBAL samples 
were diluted to a final concentration of lo- i, 10 - * 
and 10e3. Diluted and undiluted specimens were 
inoculated into blood agar, chocolate agar and 
McConKey agar, fungal media and Legionella media, 
which were incubated at 37°C under aerobic and 
anaerobic conditions on a 5% CO,-enriched atmos- 
phere (NU2500E, Nuaire, Plymouth, U.S.A.). If posi- 
tive, counts of colony-forming units per millilitre 
(CFU ml - ‘), identification and susceptibility tests 
were performed for each specimen. mpBAL samples 
were not stained for P. cavinii because of their small 
volume. The volume obtained from the different 
aliquots of BAL was pooled and divided. Half of it 
was qualitatively cultured for Mycobacteria and 
fungi. The other half was centrifuged (500 x g for 
IOmin) (Heraeus 1710, Germany). Smears were 
stained by the Papanicolau, Ziehl-Neelsen, Giemsa, 
haematoxilin-eosin and Grocott methanamine silver 
methods, but were not cultured for bacteria. Prior 
to the bronchoscopic procedure, blood samples for 
bacterial and fungal cultures were taken in all 
patients. In those patients with pleural effusion, a 
sample of pleural fluid was cultured. 
DIAGNOSTIC CRITERIA 
Patients were divided in two groups accordingly to 
the following criteria: (1) the study group, which was 
composed of patients diagnosed as having bacterial 
pneumonia because they had new pulmonary infil- 
trates and respiratory symptoms that improved with 
antibiotics (erythromycin and/or cephalosporins), 
and they did not have a positive diagnosis of P. carinii 
in BAL samples; and (2) the control group, which was 
composed by patients that either had a positive 
diagnosis of P. carinii pneumonia (or tuberculosis), or 
they did not have pulmonary infiltrates, had no 
evidence of bacterial infection (based upon micro- 
biological results) and cured without antibiotics. 
A cutoff point of IO3 CFU ml - ’ in TPC samples 
and lo4 (CFU ml - ‘) in mpBAL samples was con- 
sidered diagnostic (&lo, 11,13,14); for Legionella 
pneumophila, any count was considered diagnostic. 
Results were classified (8,10,11) as: (i) true positive 
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(TP), if micro-organisms were cultured in a 
concentration 2 IO3 CFU ml - ’ in TPC and/or 
2 lo4 CFU ml - ’ in mpBAL samples, and there was 
an adequate clinical and radiological response to 
antibiotics (erythromycin or cephalosporin); (2) false 
positive (FP), if micro-organisms were obtained in 
concentrations 2 lo3 CFU ml - ’ in TPC and/or 
2 lo4 CFU ml - ’ in mpBAL in the group of patients 
without bacterial pneumonia and they did not 
need antimicrobial therapy (erythromycin or 
cephalosporins) to cure; (3) true negative (TN), if 
micro-organisms were cultured in concentrations 
<lo3 CFUml-1 in TPC and/or <104CFUml-’ in 
mpBAL in the group of patients without bacterial 
pneumonia; and (4) false negative (FN), if there 
were no micro-organisms isolated in TPC 
( I lo3 CFU ml - ‘) and/or mpBAL ( < lo4 CFU ml - ‘) 
samples in the group of patients with bacterial 
pneumonia and the patient required antimicrobial 
therapy (erythromycin or cephalosporins). 
STATISTICAL ANALYSIS 
The sensitivity, specificity, positive predictive value 
and negative predictive value of each technique was 
calculated according to standard formulas (15): 
sensitivity =TP/(TP + FN); specificity = TN/(TN+ FP); 
positive predictive value = TP/(TP + FP); and negative 
predictive value = TN/(TN+ FN). Data are presented 
as mean ( & SD); 95% confidence intervals (CI), calcu- 
lated using standard formula (16,17), are also pro- 
vided. Differences between proportions were analysed 
using the exact probability test. A P value lower than 
0.05 was considered significant. 
Results 
The technique was well tolerated by all patients and 
there were no significant complications associated 
with it. The study group was composed of 27 patients 
(20 male and one female) with a mean age of 31 f 10 
years. Table 1 shows the different micro-organisms 
isolated in this group. Haemophilus inzuenzae was 
most frequently isolated (n= 11). In one patient (case 
11) two pathogens were isolated in TPC and mpBAL 
samples. In these 27 patients, the total number of 
isolated bacteria was 20. The control group was 
composed of 31 patients (26 male and five female) 
with a mean age of 34 f 7 years. Twenty-five individ- 
uals had P. carinii pneumonia (n=25); four of them 
had both P. cavinii pneumonia and pulmonary tuber- 
culosis. Of the remaining six subjects, two patients 
had pulmonary tuberculosis, one individual showed 
atelectasis on the chest X-ray which disappeared 
without treatment, one subject had a solitary pul- 
monary nodule (probably corresponding to an old 
tuberculous granuloma), and two patients showed 
normal chest X-ray films. These two latter individuals 
probably had a viral respiratory infection and were 
cured without antibiotics. 
Using TPC, there were 15 true positives (56%) and 
12 false negatives (44%) (Table 1) in the study group 
(n=27), and 31 true negatives (100%) and no false 
positive (0%) in the control group (n=31). Accord- 
ingly, the sensitivity of TPC was 56% (CI, 37-75%), 
its specificity loo%, its positive predictive value 100% 
and its negative predictive value 72% (CI, 59985%) 
(Table 2). Using mpBAL, there were 15 true positives 
(56%) and 12 false negatives (44%) in the study group 
(n=27) while, in the control group (n= 31), there were 
29 true negatives (94%) and two false positives (6%). 
These latter two patients were considered as false 
positives because several types of mouth bacteria 
(Neisseria sp., alpha-haemolytic Streptococcus) grew 
in mpBAL samples (Table 2), but both individuals 
were cured without antibiotics. Accordingly, the 
sensitivity of the mpBAL was 56% (CI, 37-75%), its 
specificity 94% (CI, 86-loo%), its positive predictive 
value 89% (CI, 74100%) and its negative predictive 
value 71% (CI, 57-85%) (Table 2). 
When the diagnostic yield of TPC and mpBAL was 
analysed together, there were 19 true positives (70%) 
and 8 (30%) false negatives in the study group, and 31 
true negatives (100%) and no false positives in the 
control group. Thus, the sensitivity of the combined 
method was 70% (CI, 53-87%), its specificity lOO%, 
its true predictive value 100% and its negative predic- 
tive value 79% (CI, 66-92%) (Table 2). Overall, these 
combined values were higher than those obtained 
with each technique separately. Yet, differences fail to 
reach statistical significance. Nonetheless, from the 
clinical point of view, it should be mentioned that 
four out of the 27 patients in the study group (15%, 
CI l-28%) had negative TPC cultures but positive 
mpBAL cultures (Table 1). If mpBAL had not been 
done, these patients would not have been diagnosed. 
One patient (#5) had a positive blood culture 
(S. aureus); in this patient, no micro-organism grew 
in the mpBAL sample (Table 1). Cultures of pleural 
fluid were negative in all the cases with pleural 
effusion. 
Discussion 
This study evaluates the usefulness of a new endo- 
scopic technique in the diagnosis of HIV-positive 
patients with bacterial pneumonia. The procedure 
combines a standard TPC and mpBAL performed 
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TABLE 1. Micro-organisms isolated using the telescoping plugged catheter (TPC) and 
protected bronchoalveolar lavage (mpBAL) in patients with bacterial pneumonia 
(CFU ml - ‘) 
Case TPC mpBAL 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
1 x lo3 Enterobacter tailonae 5 x lo3 Enterobacter tailonae 
1 X lo2 Serratia marcencens 4 X 104Serratia marcencens 
5 x lo3 Haemophilus influenzae 4 x IO3 Haemophilus influenzae 
No bacterial growth detected No bacterial growth detected 
2 x lo5 Staphylococcus aureus No bacterial growth detected 
No bacterial growth detected No bacterial growth detected 
2 x 10’ Haemophilus intuenzae 2 x lo4 Haemophilus infuenzae 
1 x lo4 Haemophilus injkenzae 2 x lo4 Haemophilus in$uenzae 
1 x IO4 Streptococcus viridans 5 x lo3 Streptococcus viridans 
No bacterial growth detected No bacterial growth detected 
1 x lo5 Haemophilus infuenzae 1 x lo4 Haemophilus influenzae 
1 x I O5 Streptococcus pneumoniae 1 x lo4 Streptococcus pneumoniae 
No bacterial growth detected 1 x lo5 Haemophilus inj%enzae 
6 x IO3 Haemophilus intuenzae 1 x lo5 Haemophilus injluenzae 
No bacterial growth detected No bacterial growth detected 
1 x lo4 Haemophilus infuenzae 1 x lo4 Haemophilus inJuenzae 
No bacterial growth detected 1 x IO4 Haemophilus influenzae 
1 x lo4 Haemophilus injluenzae 1 x lo6 Haemophilus influenzae 
No bacterial growth detected No bacterial growth detected 
No bacterial growth detected No bacterial growth detected 
No bacterial growth detected 1 x lo4 Staphylococcus aureus 
No bacterial growth detected No bacterial growth detected 
1 x 10’ Streptococcus pneumoniae 1 x 1 O6 Streptococcus pneumoniae 
1 x lo4 Rhodococus equi 1 x IO6 Rhodococus equi 
1 x lo6 Haemophilus injhtenzae 1 x lo6 Haemophilus injkenzae 
1 x lo6 Haemophilus influenzae 1 x lo6 Haemophilus intuenzae 
1 x lo2 Pseudomona aeuroginosa No bacterial growth detected 
1 x 10’ Staphylococcus aureus 1 x lo6 Staphylococcus aureus 
sequentially through the same catheter. Results show 
that this technique is easy to implement, well toler- 
ated and potentially useful in clinical practice. In 
addition, it reduces the economic cost of the standard 
pBAL, as originally described (10). 
CRITIQUE OF METHODS 
Three methodological aspects of this study deserve 
comment. First, strictly speaking, the technique 
used in this investigation is not a truly ‘protected’ 
bronchoalveolar lavage (pBAL). This is because, by 
design, only one catheter was used. Therefore, after 
TPC, the protected BAL had to be done without the 
distal poliethilenglicol stopper originally described by 
Meduri et al. (10). The present authors decided to 
name it modified pBAL (mpBAL) because the whole 
technique was done under sterile conditions, as 
shown by the very small number of false positives on 
mpBAL samples (Table 2). Secondly, some authors 
(812) recommended the use of nebulized anaesthesia 
to improve the diagnostic yield of the endoscopic 
procedure. Yet, others dispute this view (18). Topical 
anaesthesia through the endoscopic procedure was 
used in this study. Given that the sensitivity and 
specificity of TPC in this study were similar to those 
reported previously (19-21), the authors believe that 
the use of topical anaesthesia did not influence the 
present results. Finally, a problem common to most 
studies (including this one) in evaluating different 
diagnostic techniques is the absence of an adequate 
gold widely accepted criteria (8,10,11,13,14) to evalu- 
ate microbiological results. These criteria are helpful 
in distinguishing colonization from alveolar infection 
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TABLE 2. Efficacy analysis of telescoping plugged catheter (TPC) ,and protected broncho- 
alveolar lavage (mpBAL) 
TP FP FN TN Sensitivity Specificity PPV NPV 
64 (4 (4 (4 (%I (%) (%I (%I 
TPC 15 0 12 31 
mpBAL 15 2 12 29 
TPC+mpBAL 19 0 8 31 
(375675) 
100 100 
(5c85) 
(375675, (86YOO) 
89 71 
74-100) (57-85) 
(53Z37) 
100 100 
(667-992) 
TP, true positive; FP, false positive; FN, false negative; TN, true negative; PPV, positive 
predictive value; NPV, negative predictive value. 95% confidence intervals are shown in 
parentheses. 
(23,24). However, it may be argued that cotrimoxa- 
zole may have sterilized TPC and mpBAL samples 
in patients with P. carinii pneumonia, if they were 
co-infected by micro-organisms sensitive to this drug 
(namely, S. pneumoniae or H. injluenzae). This possi- 
bility is thought to be unlikely because, in the 
authors’ area, the most frequent bacterial pathogens 
infecting HIV-positive patients are highly resistant 
to cotrimoxazole (25-27), as recently shown by a 
long-term study (28). 
PREVIOUS STUDIES 
Bacterial pneumonia is frequent in HIV-positive 
patients (l-3). Streptococcus pneumoniae and H. 
injluenzae were the most frequently isolated micro- 
organisms in the study patients (Table 1) as described 
previously (8,9,29,30). In this investigation, TPC 
showed a sensitivity and specificity similar to that 
reported earlier in immunocompetent patients with 
pneumonia (19-21). Information on the usefulness of 
TPC in HIV-positive patients is scarce (8). Ferrer 
et al. evaluated it in 66 HIV-positive patients with 
pulmonary infiltrates, and reported a sensitivity of 
53% and a specificity of 76% (8). The present TPC 
results are slightly better (Table 2), probably because, 
contrary to Ferrer et al. (S), patients who received 
antibiotics prior to bronchoscopy were not included. 
Previous reports have shown that pBAL is a 
potentially useful technique in the diagnosis of 
immunocompetent patients with bacterial pneumonia 
(10,ll). To the authors’ knowledge, the diagnostic 
yield of pBAL in HIV-infected patients with bacterial 
pneumonia has not been assessed before. The present 
results show that in these patients, mpBAL is 
potentially useful because: (1) by itself, mpBAL 
diagnosed bacterial pneumonia in 15 patients (56%, 
CI 37-75%); (2) there was good agreement between 
the micro-organisms cultured from TPC and mpBAL 
samples (Table 1); and (3) the specificity of mpBAL 
was similar to that obtained in immunocompetent 
individuals (10,ll). However, its sensitivity was 
lower. Probably, the narrower lumen of the catheter 
employed in the present study influenced the amount 
of fluid recovered and lowered the sensitivity of the 
method. 
CLINICAL IMPLICATIONS 
This study was designed to investigate the diagnostic 
value of TPC and mpBAL performed consecutively 
through a single catheter in HIV-positive patients 
with bacterial pneumonia. The rationale was that, if 
executable and clinically useful, this approach would 
reduce the economical cost of pBAL. First, these 
results demonstrate that this technique can be easily 
implemented in the clinical practice. Second, despite 
the fact that the sensitivity and specificity of the three 
methods tested in the present investigation (TPC, 
mpBAL and TPC+mpBAL) were not significantly 
different (Table 2), several arguments led the authors 
to conclude that the combination of TPC and 
mpBAL may be clinically useful. On the one hand, 
the 95% confidence interval of TPC+mpBAL (53- 
87%) was better than that of TPC (37-75%) or 
mpBAL (37-75%) alone (Table 2). This type of 
analysis attenuates the possibility of a type II error 
(16,17). On the other, mpBAL allowed a specific 
microbiological diagnosis in 4/27 patients (Table 1). 
This represents 15% of the total population included, 
with a confidence interval of l-28%. The authors 
believe that this is clinically relevant. Finally, the 
present results show that the method used herein 
reduces the cost of the catheter originally used by 
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Meduri et al. (10) ( i 36 US$) by approximately 50%, 
because the price of a standard TPC varies around 
US$18. 
In summary, this investigation shows that the 
performance of TPC and mpBAL through a single 
catheter enhances the diagnostic yield in HIV-positive 
patients with bacterial pneumonia, and reduces the 
economical cost of pBAL. Future studies are required 
to investigate the yield of opportunistic micro- 
organisms of this approach in HIV-positive patients. 
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